RXRXRECURSION PHARMACEUTICALS, INC.同业对比
RECURSION PHARMACEUTICALS, INC. 与ARK Innovation ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:ARKK 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX本股 | $1.7B#15 | — | 1.9x#2 | 23.2x#12 | 26.9%#10 | -39.1%#12 | -867.9%#15 | -70.5%#15 | -175.2%#9 | — | -32.3%#12 | — |
| TSLA | $1.41T#2 | 330.2x#8 | 16.2x#13 | 14.9x#8 | -2.9%#15 | -46.5%#13 | 4.6%#7 | 4.4%#7 | 4.3%#4 | 5#3 | -13.1%#10 | — |
| TEM | $12M#16 | — | 0.0x#1 | 0.0x#1 | 83.4%#4 | 65.3%#6 | -19.9%#10 | -55.1%#14 | — | — | -19.2%#11 | — |
| AMD | $823.2B#3 | 129.3x#6 | 12.2x#11 | 23.8x#13 | 34.3%#8 | 164.2%#3 | 10.7%#6 | 6.4%#6 | 5.7%#3 | 8#1 | 212.9%#2 | — |
| CRSP | $5.0B#13 | — | 2.9x#4 | 1427.0x#16 | -90.6%#16 | -58.8%#15 | -18933.6%#16 | -33.3%#13 | -32.6%#6 | — | -10.5%#8 | — |
| SHOP | $168.7B#5 | 87.8x#5 | 13.3x#12 | 14.6x#7 | 30.1%#9 | -39.0%#11 | 12.7%#4 | 9.7%#5 | — | — | -12.2%#9 | — |
| ROKU | $23.2B#10 | 66.4x#4 | 8.2x#8 | 4.9x#3 | 15.2%#12 | 168.3%#2 | -0.1%#8 | 3.1%#8 | — | — | 66.8%#3 | — |
| HOOD | $99.3B#6 | 48.9x#3 | 11.6x#10 | 22.2x#10 | 51.6%#6 | 33.5%#8 | 47.1%#1 | 22.0%#2 | — | — | -3.8%#7 | — |
| COIN | $45.4B#7 | — | 3.5x#5 | 6.3x#4 | 9.4%#14 | -50.0%#14 | 20.0%#3 | 9.9%#4 | 10.9%#1 | — | -47.4%#15 | — |
| CRCL | $21.2B#11 | 17.3x#1 | 6.1x#7 | 193.5x#15 | 624.0%#1 | -144.7%#16 | -87.8%#13 | -2.0%#9 | — | — | -35.6%#14 | — |
| PLTR | $414.8B#4 | 147.5x#7 | 42.4x#15 | 92.7x#14 | 56.2%#5 | 251.6%#1 | 31.6%#2 | 16.6%#3 | — | — | 0.8%#6 | — |
| RBLX | $35.9B#9 | — | 236.1x#16 | 7.3x#5 | 35.8%#7 | -13.9%#9 | -25.2%#11 | -705.3%#16 | -724.9%#10 | — | -63.4%#16 | — |
| BEAM | $2.4B#14 | — | 2.3x#3 | 17.2x#9 | 120.0%#3 | 78.8%#5 | -274.6%#14 | -7.5%#10 | -40.5%#7 | — | 9.3%#4 | — |
| TWST | $8.6B#12 | — | 19.4x#14 | 23.0x#11 | 20.3%#11 | 62.8%#7 | -36.2%#12 | -17.4%#11 | -41.4%#8 | — | 435.7%#1 | — |
| CRWV | $43.6B#8 | — | 8.7x#9 | 8.5x#6 | 167.9%#2 | -35.3%#10 | -0.9%#9 | -23.2%#12 | -0.2%#5 | — | -32.8%#13 | — |
| AMZN | $2.68T#1 | 20.0x#2 | 4.9x#6 | 3.7x#2 | 12.4%#13 | 91.6%#4 | 11.2%#5 | 24.5%#1 | 10.7%#2 | 6#2 | 7.3%#5 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议